Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Stoeckel

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Chemotherapy|January 1, 1981
Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-lifeK Stoeckel
European Journal of Clinical Pharmacology|January 1, 1986
Biliary excretion of ceftriaxoneW Hayton, K Stoeckel
Brain Research|February 28, 1975
Retrograde axonal transport of nerve growth factor: specificity and biological importanceK Stoeckel, H Thoenen
The American Journal of Medicine|October 19, 1984
Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding modelK Stoeckel, J R Koup
Lancet (London, England)|August 13, 1994
Oral vitamin K in breast-fed infants to prevent late haemorrhagic disease of the newbornP H Joubert, K Stoeckel
Clinical Pharmacokinetics|September 1, 1993
Cefetamet pivoxil clinical pharmacokineticsR A Blouin, K Stoeckel
Clinical Pharmacokinetics|January 1, 1986
Age-associated changes in ceftriaxone pharmacokineticsW L Hayton, K Stoeckel
Antimicrobial Agents and Chemotherapy|February 1, 1982
Single-dose pharmacokinetics of ceftriaxone in infants and young childrenU B Schaad, K Stoeckel
Chemotherapy|January 1, 1992
The pharmacokinetics of new oral cephalosporins in childrenD J Edwards, K Stoeckel
Brain Research|May 16, 1975
Specificity of retrograde transport of nerve growth factor (NGF) in sensory neurons: a biochemical and morphological studyK Stoeckel, M Schwab, H Thoenen
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Chemotherapy|January 1, 1981
Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-lifeK Stoeckel
European Journal of Clinical Pharmacology|January 1, 1986
Biliary excretion of ceftriaxoneW Hayton, K Stoeckel
Brain Research|February 28, 1975
Retrograde axonal transport of nerve growth factor: specificity and biological importanceK Stoeckel, H Thoenen
The American Journal of Medicine|October 19, 1984
Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding modelK Stoeckel, J R Koup
Lancet (London, England)|August 13, 1994
Oral vitamin K in breast-fed infants to prevent late haemorrhagic disease of the newbornP H Joubert, K Stoeckel
Clinical Pharmacokinetics|September 1, 1993
Cefetamet pivoxil clinical pharmacokineticsR A Blouin, K Stoeckel
Clinical Pharmacokinetics|January 1, 1986
Age-associated changes in ceftriaxone pharmacokineticsW L Hayton, K Stoeckel
Antimicrobial Agents and Chemotherapy|February 1, 1982
Single-dose pharmacokinetics of ceftriaxone in infants and young childrenU B Schaad, K Stoeckel
Chemotherapy|January 1, 1992
The pharmacokinetics of new oral cephalosporins in childrenD J Edwards, K Stoeckel
Brain Research|May 16, 1975
Specificity of retrograde transport of nerve growth factor (NGF) in sensory neurons: a biochemical and morphological studyK Stoeckel, M Schwab, H Thoenen
Pageof 7